These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27635192)

  • 1. Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection.
    Ghasemi F; Rostami S; Ghayour-Mobarhan M; Meshkat Z
    Iran J Basic Med Sci; 2016 Jul; 19(7):692-704. PubMed ID: 27635192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present and future DNA vaccines for chronic hepatitis B treatment.
    Cova L
    Expert Opin Biol Ther; 2017 Feb; 17(2):185-195. PubMed ID: 27892722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
    Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathogenesis and therapeutic vaccine strategies for chronic hepatitis B virus infection.
    Michel ML
    Virologie (Montrouge); 2014 Feb; 18(1):25-33. PubMed ID: 32260039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on hepatitis B virus infection.
    You CR; Lee SW; Jang JW; Yoon SK
    World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck.
    Kosinska AD; Liu J; Lu M; Roggendorf M
    Med Microbiol Immunol; 2015 Feb; 204(1):103-14. PubMed ID: 25535101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress of therapeutic vaccines for treating chronic hepatitis B.
    Li J; Bao M; Ge J; Ren S; Zhou T; Qi F; Pu X; Dou J
    Hum Vaccin Immunother; 2017 May; 13(5):986-997. PubMed ID: 28118084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of viral hepatitis B.
    Pramoolsinsup C
    J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for Chronic Hepatitis B using HBsAg-based Vaccine Formulations: From Preventive Commercial Vaccines to Therapeutic Approach Julio Cesar Aguilar.
    Cesar Aguilar J; Y L
    Euroasian J Hepatogastroenterol; 2014; 4(2):92-97. PubMed ID: 29699355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV Vaccines: Advances and Development.
    Mahmood F; Xu R; Awan MUN; Song Y; Han Q; Xia X; Wei J; Xu J; Peng J; Zhang J
    Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus infection: An insight into infection outcomes and recent treatment options.
    Noordeen F
    Virusdisease; 2015 Jun; 26(1-2):1-8. PubMed ID: 26436115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance.
    Sacherl J; Kosinska AD; Kemter K; Kächele M; Laumen SC; Kerth HA; Öz EA; Wolff LS; Su J; Essbauer S; Sutter G; Scholz M; Singethan K; Altrichter J; Protzer U
    JHEP Rep; 2023 Feb; 5(2):100603. PubMed ID: 36714793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.
    Su J; Brunner L; Ates Oz E; Sacherl J; Frank G; Kerth HA; Thiele F; Wiegand M; Mogler C; Aguilar JC; Knolle PA; Collin N; Kosinska AD; Protzer U
    J Hepatol; 2023 Apr; 78(4):717-730. PubMed ID: 36634821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
    Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
    Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering immune therapy against hepatitis B virus.
    Akbar F; Yoshida O; Abe M; Hiasa Y; Onji M
    Hepatol Res; 2007 Oct; 37 Suppl 3():S351-6. PubMed ID: 17931186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of hepatitis B virus infection: pediatric perspective.
    Ni YH
    J Gastroenterol; 2011 Jan; 46(1):1-8. PubMed ID: 20812021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.